Remedent, Inc. - Current report filing (8-K)
April 15 2008 - 4:13PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 10, 2008
REMEDENT, INC.
(Exact
name of registrant as specified in its charter)
|
|
|
|
|
Nevada
|
|
001-15975
|
|
86-0837251
|
|
|
|
|
|
(State or Other Jurisdiction of
Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
|
|
|
|
|
|
|
Xavier de Cocklaan 42, 9831, Deurle, Belgium
|
|
|
|
N/A
|
|
|
|
|
|
(Address of Principal Executive Offices)
|
|
|
|
(Zip Code)
|
011-329-321-7080
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
o
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
TABLE OF CONTENTS
SECTION 1 REGISTRANTS BUSINESS AND OPERATIONS
Item 1.01 Entry into a Material Definitive Agreement.
On April 10, 2008, Remedent N.V., a Belgian company
and a subsidiary of Remedent, Inc. (Company),
entered into a distribution agreement (Agreement) with
GlamTech USA, Inc., a corporation under
the laws of Delaware (GlamTech) whereby GlamTech agreed to be the exclusive distributor of the
Companys GlamSmile products in the United States of America and Canada.
The term of the Agreement will be for five years and will begin on April 10, 2008.
The Agreement is filed as Exhibit 10.1 to this Form 8-K. As the Company has applied for
confidential treatment from the Securities and Exchange Commission with respect to certain
commercially sensitive pricing terms contained in the Agreements, such terms have been redacted
from Exhibit 10.1 and have been replaced by the symbol [ *** ].
For further information see the Agreement attached hereto as Exhibit 10.1.
SECTION 5CORPORATE GOVERNANCE AND MANAGEMENT
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective April 30, 2008, Roger Leddington is resigning his position as Senior Vice President and
Head of US Marketing for Remedent. Mr. Leddington guided GlamSmiles entry into the US market late
last year, and in conjunction with the GlamTech USA, Inc. Distribution Agreement, Mr. Leddington
accepted the position as GlamTechs President.
SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
Item 9.01. Financial Statements and Exhibits.
|
|
|
|
|
Exhibit No.
|
|
Exhibit Description
|
|
|
|
|
|
|
10.1
|
|
|
Distribution Agreement, dated April 10, 2008, by and between
Remedent n.v and GlamTech USA, Inc. *
|
|
|
|
|
|
|
99.1
|
|
|
Press
Release dated April 15, 2008, Remedent, Inc. Announces
launch of Exclusive Strategic Marketing Program with GlamTech USA,
Inc. for the Distribution of Glamsmile in the United States and
Canada
|
|
|
|
|
|
|
|
|
*
|
|
Application has been made to the Securities and Exchange Commission to seek confidential
treatment of certain portions of this Exhibit 10.1 under Rule 24b-2 of the Securities Exchange Act
of 1934, as amended. Omitted material for which confidential treatment has been requested has been
filed separately with the Securities and Exchange Commission.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
REMEDENT, INC.
,
a Nevada corporation
|
|
Dated: April 14, 2008
|
By:
|
/s/ Robin List
|
|
|
|
Robin List,
|
|
|
|
Chief Executive Officer
|
|
EXHIBIT INDEX
|
|
|
|
|
Exhibit No.
|
|
Exhibit Description
|
|
|
|
|
|
|
10.1
|
|
|
Distribution Agreement, dated April 10, 2008, by and between
Remedent n.v and GlamTech USA, Inc. *
|
|
|
|
|
|
|
99.1
|
|
|
Press
Release dated April 15, 2008, Remedent, Inc. Announces
launch of Exclusive Strategic Marketing Program with GlamTech USA,
Inc. for the Distribution of Glamsmile in the United States and
Canada
|
|
|
|
*
|
|
Application has been made to the Securities and Exchange Commission to seek confidential
treatment of certain portions of this Exhibit 10.1 under Rule 24b-2 of the Securities Exchange Act
of 1934, as amended. Omitted material for which confidential treatment has been requested has been
filed separately with the Securities and Exchange Commission.
|
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jul 2023 to Jul 2024